nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Gemfibrozil—coronary artery disease	0.0753	0.436	CbGbCtD
Guanabenz—CYP1A2—Clopidogrel—coronary artery disease	0.0653	0.378	CbGbCtD
Guanabenz—CYP1A2—Losartan—coronary artery disease	0.0319	0.185	CbGbCtD
Guanabenz—Guanfacine—CYP2C19—coronary artery disease	0.003	1	CrCbGaD
Guanabenz—Gastrointestinal pain—Perindopril—coronary artery disease	0.000191	0.000323	CcSEcCtD
Guanabenz—Anxiety—Timolol—coronary artery disease	0.000191	0.000322	CcSEcCtD
Guanabenz—Angioedema—Lisinopril—coronary artery disease	0.00019	0.000322	CcSEcCtD
Guanabenz—Pruritus—Olmesartan—coronary artery disease	0.00019	0.000322	CcSEcCtD
Guanabenz—Decreased appetite—Losartan—coronary artery disease	0.00019	0.000322	CcSEcCtD
Guanabenz—Abdominal pain—Captopril—coronary artery disease	0.00019	0.000321	CcSEcCtD
Guanabenz—Body temperature increased—Captopril—coronary artery disease	0.00019	0.000321	CcSEcCtD
Guanabenz—Dizziness—Simvastatin—coronary artery disease	0.000189	0.00032	CcSEcCtD
Guanabenz—Rash—Ezetimibe—coronary artery disease	0.000189	0.00032	CcSEcCtD
Guanabenz—Dermatitis—Ezetimibe—coronary artery disease	0.000189	0.00032	CcSEcCtD
Guanabenz—Confusional state—Ramipril—coronary artery disease	0.000189	0.00032	CcSEcCtD
Guanabenz—Discomfort—Timolol—coronary artery disease	0.000189	0.00032	CcSEcCtD
Guanabenz—Asthenia—Niacin—coronary artery disease	0.000189	0.000319	CcSEcCtD
Guanabenz—Fatigue—Losartan—coronary artery disease	0.000188	0.000319	CcSEcCtD
Guanabenz—Headache—Ezetimibe—coronary artery disease	0.000188	0.000318	CcSEcCtD
Guanabenz—Malaise—Lisinopril—coronary artery disease	0.000188	0.000318	CcSEcCtD
Guanabenz—Oedema—Ramipril—coronary artery disease	0.000187	0.000317	CcSEcCtD
Guanabenz—Dry mouth—Timolol—coronary artery disease	0.000187	0.000316	CcSEcCtD
Guanabenz—Constipation—Losartan—coronary artery disease	0.000187	0.000316	CcSEcCtD
Guanabenz—Pain—Losartan—coronary artery disease	0.000187	0.000316	CcSEcCtD
Guanabenz—Syncope—Lisinopril—coronary artery disease	0.000187	0.000316	CcSEcCtD
Guanabenz—Vomiting—Eplerenone—coronary artery disease	0.000187	0.000316	CcSEcCtD
Guanabenz—Feeling abnormal—Furosemide—coronary artery disease	0.000187	0.000316	CcSEcCtD
Guanabenz—Leukopenia—Lisinopril—coronary artery disease	0.000186	0.000316	CcSEcCtD
Guanabenz—Nausea—Fenofibrate—coronary artery disease	0.000186	0.000315	CcSEcCtD
Guanabenz—Pruritus—Niacin—coronary artery disease	0.000186	0.000315	CcSEcCtD
Guanabenz—Asthenia—Pravastatin—coronary artery disease	0.000186	0.000314	CcSEcCtD
Guanabenz—Gastrointestinal pain—Furosemide—coronary artery disease	0.000185	0.000314	CcSEcCtD
Guanabenz—Rash—Eplerenone—coronary artery disease	0.000185	0.000313	CcSEcCtD
Guanabenz—Urticaria—Perindopril—coronary artery disease	0.000185	0.000313	CcSEcCtD
Guanabenz—Hypersensitivity—Trandolapril—coronary artery disease	0.000185	0.000313	CcSEcCtD
Guanabenz—Dermatitis—Eplerenone—coronary artery disease	0.000185	0.000313	CcSEcCtD
Guanabenz—Diarrhoea—Valsartan—coronary artery disease	0.000185	0.000313	CcSEcCtD
Guanabenz—Confusional state—Timolol—coronary artery disease	0.000185	0.000313	CcSEcCtD
Guanabenz—Shock—Ramipril—coronary artery disease	0.000184	0.000312	CcSEcCtD
Guanabenz—Hypersensitivity—Enalapril—coronary artery disease	0.000184	0.000312	CcSEcCtD
Guanabenz—Abdominal pain—Perindopril—coronary artery disease	0.000184	0.000312	CcSEcCtD
Guanabenz—Body temperature increased—Perindopril—coronary artery disease	0.000184	0.000312	CcSEcCtD
Guanabenz—Diarrhoea—Olmesartan—coronary artery disease	0.000184	0.000311	CcSEcCtD
Guanabenz—Headache—Eplerenone—coronary artery disease	0.000184	0.000311	CcSEcCtD
Guanabenz—Nervous system disorder—Ramipril—coronary artery disease	0.000184	0.000311	CcSEcCtD
Guanabenz—Thrombocytopenia—Ramipril—coronary artery disease	0.000184	0.000311	CcSEcCtD
Guanabenz—Oedema—Timolol—coronary artery disease	0.000183	0.00031	CcSEcCtD
Guanabenz—Pruritus—Pravastatin—coronary artery disease	0.000183	0.00031	CcSEcCtD
Guanabenz—Loss of consciousness—Lisinopril—coronary artery disease	0.000183	0.00031	CcSEcCtD
Guanabenz—Nausea—Clopidogrel—coronary artery disease	0.000183	0.00031	CcSEcCtD
Guanabenz—Tachycardia—Ramipril—coronary artery disease	0.000183	0.00031	CcSEcCtD
Guanabenz—Skin disorder—Ramipril—coronary artery disease	0.000182	0.000308	CcSEcCtD
Guanabenz—Infection—Timolol—coronary artery disease	0.000182	0.000308	CcSEcCtD
Guanabenz—Vomiting—Simvastatin—coronary artery disease	0.000182	0.000308	CcSEcCtD
Guanabenz—Hypersensitivity—Telmisartan—coronary artery disease	0.000182	0.000308	CcSEcCtD
Guanabenz—Cough—Lisinopril—coronary artery disease	0.000182	0.000308	CcSEcCtD
Guanabenz—Nausea—Lovastatin—coronary artery disease	0.000182	0.000308	CcSEcCtD
Guanabenz—Rash—Simvastatin—coronary artery disease	0.00018	0.000305	CcSEcCtD
Guanabenz—Dermatitis—Simvastatin—coronary artery disease	0.00018	0.000305	CcSEcCtD
Guanabenz—Asthenia—Trandolapril—coronary artery disease	0.00018	0.000305	CcSEcCtD
Guanabenz—Shock—Timolol—coronary artery disease	0.00018	0.000305	CcSEcCtD
Guanabenz—Feeling abnormal—Losartan—coronary artery disease	0.00018	0.000305	CcSEcCtD
Guanabenz—Urticaria—Furosemide—coronary artery disease	0.00018	0.000305	CcSEcCtD
Guanabenz—Diarrhoea—Niacin—coronary artery disease	0.00018	0.000304	CcSEcCtD
Guanabenz—Nervous system disorder—Timolol—coronary artery disease	0.00018	0.000304	CcSEcCtD
Guanabenz—Asthenia—Enalapril—coronary artery disease	0.00018	0.000304	CcSEcCtD
Guanabenz—Headache—Simvastatin—coronary artery disease	0.000179	0.000303	CcSEcCtD
Guanabenz—Body temperature increased—Furosemide—coronary artery disease	0.000179	0.000303	CcSEcCtD
Guanabenz—Abdominal pain—Furosemide—coronary artery disease	0.000179	0.000303	CcSEcCtD
Guanabenz—Gastrointestinal pain—Losartan—coronary artery disease	0.000179	0.000303	CcSEcCtD
Guanabenz—Dizziness—Valsartan—coronary artery disease	0.000179	0.000302	CcSEcCtD
Guanabenz—Anorexia—Ramipril—coronary artery disease	0.000179	0.000302	CcSEcCtD
Guanabenz—Nausea—Ezetimibe—coronary artery disease	0.000178	0.000302	CcSEcCtD
Guanabenz—Skin disorder—Timolol—coronary artery disease	0.000178	0.000301	CcSEcCtD
Guanabenz—Dizziness—Olmesartan—coronary artery disease	0.000178	0.000301	CcSEcCtD
Guanabenz—Pruritus—Trandolapril—coronary artery disease	0.000178	0.000301	CcSEcCtD
Guanabenz—Arthralgia—Lisinopril—coronary artery disease	0.000177	0.0003	CcSEcCtD
Guanabenz—Chest pain—Lisinopril—coronary artery disease	0.000177	0.0003	CcSEcCtD
Guanabenz—Myalgia—Lisinopril—coronary artery disease	0.000177	0.0003	CcSEcCtD
Guanabenz—Asthenia—Telmisartan—coronary artery disease	0.000177	0.0003	CcSEcCtD
Guanabenz—Pruritus—Enalapril—coronary artery disease	0.000177	0.0003	CcSEcCtD
Guanabenz—Diarrhoea—Pravastatin—coronary artery disease	0.000177	0.0003	CcSEcCtD
Guanabenz—Anxiety—Lisinopril—coronary artery disease	0.000177	0.000299	CcSEcCtD
Guanabenz—Discomfort—Lisinopril—coronary artery disease	0.000175	0.000296	CcSEcCtD
Guanabenz—Hypotension—Ramipril—coronary artery disease	0.000175	0.000296	CcSEcCtD
Guanabenz—Anorexia—Timolol—coronary artery disease	0.000175	0.000296	CcSEcCtD
Guanabenz—Pruritus—Telmisartan—coronary artery disease	0.000175	0.000296	CcSEcCtD
Guanabenz—Nausea—Eplerenone—coronary artery disease	0.000175	0.000295	CcSEcCtD
Guanabenz—Dizziness—Niacin—coronary artery disease	0.000174	0.000294	CcSEcCtD
Guanabenz—Urticaria—Losartan—coronary artery disease	0.000174	0.000294	CcSEcCtD
Guanabenz—Dry mouth—Lisinopril—coronary artery disease	0.000173	0.000293	CcSEcCtD
Guanabenz—Body temperature increased—Losartan—coronary artery disease	0.000173	0.000292	CcSEcCtD
Guanabenz—Abdominal pain—Losartan—coronary artery disease	0.000173	0.000292	CcSEcCtD
Guanabenz—Asthenia—Captopril—coronary artery disease	0.000172	0.000291	CcSEcCtD
Guanabenz—Diarrhoea—Trandolapril—coronary artery disease	0.000172	0.000291	CcSEcCtD
Guanabenz—Vomiting—Valsartan—coronary artery disease	0.000172	0.000291	CcSEcCtD
Guanabenz—Confusional state—Lisinopril—coronary artery disease	0.000171	0.00029	CcSEcCtD
Guanabenz—Diarrhoea—Enalapril—coronary artery disease	0.000171	0.00029	CcSEcCtD
Guanabenz—Hypotension—Timolol—coronary artery disease	0.000171	0.00029	CcSEcCtD
Guanabenz—Dizziness—Pravastatin—coronary artery disease	0.000171	0.00029	CcSEcCtD
Guanabenz—Vomiting—Olmesartan—coronary artery disease	0.000171	0.000289	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000171	0.000289	CcSEcCtD
Guanabenz—Rash—Valsartan—coronary artery disease	0.00017	0.000288	CcSEcCtD
Guanabenz—Dermatitis—Valsartan—coronary artery disease	0.00017	0.000288	CcSEcCtD
Guanabenz—Nausea—Simvastatin—coronary artery disease	0.00017	0.000288	CcSEcCtD
Guanabenz—Oedema—Lisinopril—coronary artery disease	0.00017	0.000288	CcSEcCtD
Guanabenz—Pruritus—Captopril—coronary artery disease	0.00017	0.000287	CcSEcCtD
Guanabenz—Rash—Olmesartan—coronary artery disease	0.00017	0.000287	CcSEcCtD
Guanabenz—Dermatitis—Olmesartan—coronary artery disease	0.000169	0.000287	CcSEcCtD
Guanabenz—Headache—Valsartan—coronary artery disease	0.000169	0.000287	CcSEcCtD
Guanabenz—Diarrhoea—Telmisartan—coronary artery disease	0.000169	0.000286	CcSEcCtD
Guanabenz—Infection—Lisinopril—coronary artery disease	0.000169	0.000286	CcSEcCtD
Guanabenz—Headache—Olmesartan—coronary artery disease	0.000169	0.000285	CcSEcCtD
Guanabenz—Paraesthesia—Ramipril—coronary artery disease	0.000168	0.000285	CcSEcCtD
Guanabenz—Shock—Lisinopril—coronary artery disease	0.000167	0.000283	CcSEcCtD
Guanabenz—Asthenia—Perindopril—coronary artery disease	0.000167	0.000283	CcSEcCtD
Guanabenz—Dyspnoea—Ramipril—coronary artery disease	0.000167	0.000283	CcSEcCtD
Guanabenz—Vomiting—Niacin—coronary artery disease	0.000167	0.000283	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000167	0.000283	CcSEcCtD
Guanabenz—Hypersensitivity—Furosemide—coronary artery disease	0.000167	0.000282	CcSEcCtD
Guanabenz—Thrombocytopenia—Lisinopril—coronary artery disease	0.000166	0.000282	CcSEcCtD
Guanabenz—Dizziness—Trandolapril—coronary artery disease	0.000166	0.000281	CcSEcCtD
Guanabenz—Tachycardia—Lisinopril—coronary artery disease	0.000166	0.000281	CcSEcCtD
Guanabenz—Rash—Niacin—coronary artery disease	0.000166	0.00028	CcSEcCtD
Guanabenz—Dermatitis—Niacin—coronary artery disease	0.000166	0.00028	CcSEcCtD
Guanabenz—Dizziness—Enalapril—coronary artery disease	0.000166	0.00028	CcSEcCtD
Guanabenz—Skin disorder—Lisinopril—coronary artery disease	0.000165	0.000279	CcSEcCtD
Guanabenz—Dyspepsia—Ramipril—coronary artery disease	0.000165	0.000279	CcSEcCtD
Guanabenz—Pruritus—Perindopril—coronary artery disease	0.000165	0.000279	CcSEcCtD
Guanabenz—Headache—Niacin—coronary artery disease	0.000165	0.000279	CcSEcCtD
Guanabenz—Paraesthesia—Timolol—coronary artery disease	0.000165	0.000278	CcSEcCtD
Guanabenz—Vomiting—Pravastatin—coronary artery disease	0.000165	0.000278	CcSEcCtD
Guanabenz—Diarrhoea—Captopril—coronary artery disease	0.000164	0.000278	CcSEcCtD
Guanabenz—Dyspnoea—Timolol—coronary artery disease	0.000163	0.000276	CcSEcCtD
Guanabenz—Dizziness—Telmisartan—coronary artery disease	0.000163	0.000276	CcSEcCtD
Guanabenz—Rash—Pravastatin—coronary artery disease	0.000163	0.000276	CcSEcCtD
Guanabenz—Dermatitis—Pravastatin—coronary artery disease	0.000163	0.000276	CcSEcCtD
Guanabenz—Decreased appetite—Ramipril—coronary artery disease	0.000163	0.000276	CcSEcCtD
Guanabenz—Asthenia—Furosemide—coronary artery disease	0.000163	0.000275	CcSEcCtD
Guanabenz—Headache—Pravastatin—coronary artery disease	0.000162	0.000274	CcSEcCtD
Guanabenz—Anorexia—Lisinopril—coronary artery disease	0.000162	0.000274	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000162	0.000274	CcSEcCtD
Guanabenz—Fatigue—Ramipril—coronary artery disease	0.000162	0.000273	CcSEcCtD
Guanabenz—Dyspepsia—Timolol—coronary artery disease	0.000161	0.000273	CcSEcCtD
Guanabenz—Hypersensitivity—Losartan—coronary artery disease	0.000161	0.000273	CcSEcCtD
Guanabenz—Nausea—Valsartan—coronary artery disease	0.000161	0.000272	CcSEcCtD
Guanabenz—Pruritus—Furosemide—coronary artery disease	0.00016	0.000271	CcSEcCtD
Guanabenz—Constipation—Ramipril—coronary artery disease	0.00016	0.000271	CcSEcCtD
Guanabenz—Nausea—Olmesartan—coronary artery disease	0.00016	0.00027	CcSEcCtD
Guanabenz—Vomiting—Trandolapril—coronary artery disease	0.00016	0.00027	CcSEcCtD
Guanabenz—Diarrhoea—Perindopril—coronary artery disease	0.000159	0.00027	CcSEcCtD
Guanabenz—Decreased appetite—Timolol—coronary artery disease	0.000159	0.00027	CcSEcCtD
Guanabenz—Vomiting—Enalapril—coronary artery disease	0.000159	0.000269	CcSEcCtD
Guanabenz—Hypotension—Lisinopril—coronary artery disease	0.000159	0.000269	CcSEcCtD
Guanabenz—Dizziness—Captopril—coronary artery disease	0.000159	0.000269	CcSEcCtD
Guanabenz—Rash—Trandolapril—coronary artery disease	0.000158	0.000268	CcSEcCtD
Guanabenz—Dermatitis—Trandolapril—coronary artery disease	0.000158	0.000268	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Timolol—coronary artery disease	0.000158	0.000268	CcSEcCtD
Guanabenz—Fatigue—Timolol—coronary artery disease	0.000158	0.000267	CcSEcCtD
Guanabenz—Rash—Enalapril—coronary artery disease	0.000158	0.000267	CcSEcCtD
Guanabenz—Dermatitis—Enalapril—coronary artery disease	0.000158	0.000267	CcSEcCtD
Guanabenz—Headache—Trandolapril—coronary artery disease	0.000157	0.000266	CcSEcCtD
Guanabenz—Vomiting—Telmisartan—coronary artery disease	0.000157	0.000266	CcSEcCtD
Guanabenz—Asthenia—Losartan—coronary artery disease	0.000157	0.000265	CcSEcCtD
Guanabenz—Headache—Enalapril—coronary artery disease	0.000157	0.000265	CcSEcCtD
Guanabenz—Pain—Timolol—coronary artery disease	0.000157	0.000265	CcSEcCtD
Guanabenz—Nausea—Niacin—coronary artery disease	0.000156	0.000264	CcSEcCtD
Guanabenz—Rash—Telmisartan—coronary artery disease	0.000156	0.000263	CcSEcCtD
Guanabenz—Dermatitis—Telmisartan—coronary artery disease	0.000156	0.000263	CcSEcCtD
Guanabenz—Diarrhoea—Furosemide—coronary artery disease	0.000155	0.000262	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000155	0.000262	CcSEcCtD
Guanabenz—Pruritus—Losartan—coronary artery disease	0.000155	0.000262	CcSEcCtD
Guanabenz—Headache—Telmisartan—coronary artery disease	0.000155	0.000262	CcSEcCtD
Guanabenz—Feeling abnormal—Ramipril—coronary artery disease	0.000154	0.000261	CcSEcCtD
Guanabenz—Dizziness—Perindopril—coronary artery disease	0.000154	0.000261	CcSEcCtD
Guanabenz—Nausea—Pravastatin—coronary artery disease	0.000154	0.00026	CcSEcCtD
Guanabenz—Gastrointestinal pain—Ramipril—coronary artery disease	0.000153	0.000259	CcSEcCtD
Guanabenz—Paraesthesia—Lisinopril—coronary artery disease	0.000153	0.000258	CcSEcCtD
Guanabenz—Vomiting—Captopril—coronary artery disease	0.000153	0.000258	CcSEcCtD
Guanabenz—Dyspnoea—Lisinopril—coronary artery disease	0.000152	0.000256	CcSEcCtD
Guanabenz—Rash—Captopril—coronary artery disease	0.000151	0.000256	CcSEcCtD
Guanabenz—Dermatitis—Captopril—coronary artery disease	0.000151	0.000256	CcSEcCtD
Guanabenz—Feeling abnormal—Timolol—coronary artery disease	0.000151	0.000256	CcSEcCtD
Guanabenz—Headache—Captopril—coronary artery disease	0.00015	0.000254	CcSEcCtD
Guanabenz—Gastrointestinal pain—Timolol—coronary artery disease	0.00015	0.000254	CcSEcCtD
Guanabenz—Dizziness—Furosemide—coronary artery disease	0.00015	0.000254	CcSEcCtD
Guanabenz—Dyspepsia—Lisinopril—coronary artery disease	0.00015	0.000253	CcSEcCtD
Guanabenz—Diarrhoea—Losartan—coronary artery disease	0.00015	0.000253	CcSEcCtD
Guanabenz—Nausea—Trandolapril—coronary artery disease	0.000149	0.000253	CcSEcCtD
Guanabenz—Urticaria—Ramipril—coronary artery disease	0.000149	0.000252	CcSEcCtD
Guanabenz—Nausea—Enalapril—coronary artery disease	0.000149	0.000252	CcSEcCtD
Guanabenz—Vomiting—Perindopril—coronary artery disease	0.000148	0.000251	CcSEcCtD
Guanabenz—Abdominal pain—Ramipril—coronary artery disease	0.000148	0.000251	CcSEcCtD
Guanabenz—Body temperature increased—Ramipril—coronary artery disease	0.000148	0.000251	CcSEcCtD
Guanabenz—Decreased appetite—Lisinopril—coronary artery disease	0.000148	0.00025	CcSEcCtD
Guanabenz—Rash—Perindopril—coronary artery disease	0.000147	0.000249	CcSEcCtD
Guanabenz—Dermatitis—Perindopril—coronary artery disease	0.000147	0.000248	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000147	0.000248	CcSEcCtD
Guanabenz—Nausea—Telmisartan—coronary artery disease	0.000147	0.000248	CcSEcCtD
Guanabenz—Fatigue—Lisinopril—coronary artery disease	0.000147	0.000248	CcSEcCtD
Guanabenz—Headache—Perindopril—coronary artery disease	0.000146	0.000247	CcSEcCtD
Guanabenz—Urticaria—Timolol—coronary artery disease	0.000146	0.000246	CcSEcCtD
Guanabenz—Pain—Lisinopril—coronary artery disease	0.000145	0.000246	CcSEcCtD
Guanabenz—Constipation—Lisinopril—coronary artery disease	0.000145	0.000246	CcSEcCtD
Guanabenz—Abdominal pain—Timolol—coronary artery disease	0.000145	0.000245	CcSEcCtD
Guanabenz—Body temperature increased—Timolol—coronary artery disease	0.000145	0.000245	CcSEcCtD
Guanabenz—Dizziness—Losartan—coronary artery disease	0.000145	0.000245	CcSEcCtD
Guanabenz—Vomiting—Furosemide—coronary artery disease	0.000144	0.000244	CcSEcCtD
Guanabenz—Rash—Furosemide—coronary artery disease	0.000143	0.000242	CcSEcCtD
Guanabenz—Dermatitis—Furosemide—coronary artery disease	0.000143	0.000242	CcSEcCtD
Guanabenz—Nausea—Captopril—coronary artery disease	0.000143	0.000241	CcSEcCtD
Guanabenz—Headache—Furosemide—coronary artery disease	0.000142	0.00024	CcSEcCtD
Guanabenz—Feeling abnormal—Lisinopril—coronary artery disease	0.00014	0.000237	CcSEcCtD
Guanabenz—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000139	0.000235	CcSEcCtD
Guanabenz—Vomiting—Losartan—coronary artery disease	0.000139	0.000235	CcSEcCtD
Guanabenz—Nausea—Perindopril—coronary artery disease	0.000138	0.000234	CcSEcCtD
Guanabenz—Hypersensitivity—Ramipril—coronary artery disease	0.000138	0.000234	CcSEcCtD
Guanabenz—Rash—Losartan—coronary artery disease	0.000138	0.000233	CcSEcCtD
Guanabenz—Dermatitis—Losartan—coronary artery disease	0.000138	0.000233	CcSEcCtD
Guanabenz—Headache—Losartan—coronary artery disease	0.000137	0.000232	CcSEcCtD
Guanabenz—Urticaria—Lisinopril—coronary artery disease	0.000135	0.000229	CcSEcCtD
Guanabenz—Hypersensitivity—Timolol—coronary artery disease	0.000135	0.000228	CcSEcCtD
Guanabenz—Nausea—Furosemide—coronary artery disease	0.000135	0.000228	CcSEcCtD
Guanabenz—Asthenia—Ramipril—coronary artery disease	0.000134	0.000228	CcSEcCtD
Guanabenz—Body temperature increased—Lisinopril—coronary artery disease	0.000134	0.000227	CcSEcCtD
Guanabenz—Abdominal pain—Lisinopril—coronary artery disease	0.000134	0.000227	CcSEcCtD
Guanabenz—Pruritus—Ramipril—coronary artery disease	0.000133	0.000224	CcSEcCtD
Guanabenz—Asthenia—Timolol—coronary artery disease	0.000131	0.000222	CcSEcCtD
Guanabenz—Nausea—Losartan—coronary artery disease	0.00013	0.00022	CcSEcCtD
Guanabenz—Pruritus—Timolol—coronary artery disease	0.00013	0.000219	CcSEcCtD
Guanabenz—Diarrhoea—Ramipril—coronary artery disease	0.000128	0.000217	CcSEcCtD
Guanabenz—Diarrhoea—Timolol—coronary artery disease	0.000125	0.000212	CcSEcCtD
Guanabenz—Hypersensitivity—Lisinopril—coronary artery disease	0.000125	0.000212	CcSEcCtD
Guanabenz—Dizziness—Ramipril—coronary artery disease	0.000124	0.00021	CcSEcCtD
Guanabenz—Asthenia—Lisinopril—coronary artery disease	0.000122	0.000206	CcSEcCtD
Guanabenz—Dizziness—Timolol—coronary artery disease	0.000121	0.000205	CcSEcCtD
Guanabenz—Pruritus—Lisinopril—coronary artery disease	0.00012	0.000204	CcSEcCtD
Guanabenz—Vomiting—Ramipril—coronary artery disease	0.000119	0.000202	CcSEcCtD
Guanabenz—Rash—Ramipril—coronary artery disease	0.000118	0.0002	CcSEcCtD
Guanabenz—Dermatitis—Ramipril—coronary artery disease	0.000118	0.0002	CcSEcCtD
Guanabenz—Headache—Ramipril—coronary artery disease	0.000117	0.000199	CcSEcCtD
Guanabenz—Vomiting—Timolol—coronary artery disease	0.000117	0.000197	CcSEcCtD
Guanabenz—Diarrhoea—Lisinopril—coronary artery disease	0.000116	0.000197	CcSEcCtD
Guanabenz—Rash—Timolol—coronary artery disease	0.000116	0.000196	CcSEcCtD
Guanabenz—Dermatitis—Timolol—coronary artery disease	0.000115	0.000195	CcSEcCtD
Guanabenz—Headache—Timolol—coronary artery disease	0.000115	0.000194	CcSEcCtD
Guanabenz—Dizziness—Lisinopril—coronary artery disease	0.000112	0.00019	CcSEcCtD
Guanabenz—Nausea—Ramipril—coronary artery disease	0.000111	0.000188	CcSEcCtD
Guanabenz—Nausea—Timolol—coronary artery disease	0.000109	0.000184	CcSEcCtD
Guanabenz—Vomiting—Lisinopril—coronary artery disease	0.000108	0.000183	CcSEcCtD
Guanabenz—Rash—Lisinopril—coronary artery disease	0.000107	0.000181	CcSEcCtD
Guanabenz—Dermatitis—Lisinopril—coronary artery disease	0.000107	0.000181	CcSEcCtD
Guanabenz—Headache—Lisinopril—coronary artery disease	0.000107	0.00018	CcSEcCtD
Guanabenz—Nausea—Lisinopril—coronary artery disease	0.000101	0.000171	CcSEcCtD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.9e-05	8.15e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CSF2—coronary artery disease	1.9e-05	8.13e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGF1—coronary artery disease	1.9e-05	8.13e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PPP2CA—coronary artery disease	1.89e-05	8.11e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—coronary artery disease	1.89e-05	8.09e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LPL—coronary artery disease	1.89e-05	8.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.88e-05	8.06e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ITGAV—coronary artery disease	1.88e-05	8.04e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—coronary artery disease	1.88e-05	8.03e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KNG1—coronary artery disease	1.87e-05	8.02e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RPS6KB1—coronary artery disease	1.87e-05	8e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MEF2C—coronary artery disease	1.87e-05	8e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOA1—coronary artery disease	1.87e-05	8e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—POMC—coronary artery disease	1.87e-05	7.99e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CREB1—coronary artery disease	1.87e-05	7.99e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GSTM1—coronary artery disease	1.87e-05	7.99e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGTR1—coronary artery disease	1.86e-05	7.97e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCD—coronary artery disease	1.86e-05	7.96e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—MAPK1—coronary artery disease	1.84e-05	7.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPL—coronary artery disease	1.83e-05	7.84e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—coronary artery disease	1.83e-05	7.82e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6R—coronary artery disease	1.82e-05	7.8e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ITGB3—coronary artery disease	1.82e-05	7.8e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2A—coronary artery disease	1.82e-05	7.79e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL10—coronary artery disease	1.82e-05	7.79e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—C3—coronary artery disease	1.82e-05	7.78e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLG—coronary artery disease	1.81e-05	7.77e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—VCAN—coronary artery disease	1.81e-05	7.77e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALDOA—coronary artery disease	1.8e-05	7.71e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPX1—coronary artery disease	1.79e-05	7.65e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL8—coronary artery disease	1.78e-05	7.61e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PPP2CA—coronary artery disease	1.77e-05	7.58e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRB2—coronary artery disease	1.77e-05	7.56e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—DCN—coronary artery disease	1.75e-05	7.48e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCE—coronary artery disease	1.74e-05	7.47e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—JAK2—coronary artery disease	1.74e-05	7.46e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD36—coronary artery disease	1.74e-05	7.45e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOCS1—coronary artery disease	1.74e-05	7.45e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCD—coronary artery disease	1.74e-05	7.44e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—S100B—coronary artery disease	1.74e-05	7.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HIF1A—coronary artery disease	1.73e-05	7.42e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGT—coronary artery disease	1.73e-05	7.39e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—coronary artery disease	1.72e-05	7.36e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPP2CA—coronary artery disease	1.72e-05	7.36e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOCS3—coronary artery disease	1.72e-05	7.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALDH2—coronary artery disease	1.7e-05	7.28e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2A—coronary artery disease	1.7e-05	7.28e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KITLG—coronary artery disease	1.7e-05	7.27e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFBR2—coronary artery disease	1.7e-05	7.27e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—C3—coronary artery disease	1.7e-05	7.27e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—coronary artery disease	1.69e-05	7.25e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—coronary artery disease	1.69e-05	7.25e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—coronary artery disease	1.67e-05	7.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT5A—coronary artery disease	1.66e-05	7.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP3—coronary artery disease	1.66e-05	7.11e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KDR—coronary artery disease	1.66e-05	7.1e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.66e-05	7.1e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HBA1—coronary artery disease	1.66e-05	7.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2C19—coronary artery disease	1.66e-05	7.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LIPC—coronary artery disease	1.66e-05	7.09e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	1.66e-05	7.09e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—coronary artery disease	1.65e-05	7.06e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK14—coronary artery disease	1.65e-05	7.05e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOC3—coronary artery disease	1.65e-05	7.05e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—coronary artery disease	1.65e-05	7.05e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LDLR—coronary artery disease	1.64e-05	7.01e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.64e-05	7e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—coronary artery disease	1.62e-05	6.95e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—coronary artery disease	1.62e-05	6.93e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC9A1—coronary artery disease	1.62e-05	6.92e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTT1—coronary artery disease	1.62e-05	6.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ESR1—coronary artery disease	1.62e-05	6.92e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—coronary artery disease	1.61e-05	6.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—coronary artery disease	1.61e-05	6.87e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOB—coronary artery disease	1.6e-05	6.87e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCLC—coronary artery disease	1.6e-05	6.85e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CETP—coronary artery disease	1.6e-05	6.85e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	1.6e-05	6.84e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FN1—coronary artery disease	1.6e-05	6.83e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—F2—coronary artery disease	1.6e-05	6.83e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	1.59e-05	6.81e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6ST—coronary artery disease	1.59e-05	6.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	1.58e-05	6.78e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SDC1—coronary artery disease	1.58e-05	6.77e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—coronary artery disease	1.58e-05	6.77e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—coronary artery disease	1.58e-05	6.77e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	1.58e-05	6.76e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NFKBIA—coronary artery disease	1.58e-05	6.75e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—coronary artery disease	1.57e-05	6.71e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	1.57e-05	6.71e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—coronary artery disease	1.56e-05	6.69e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KDR—coronary artery disease	1.55e-05	6.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	1.54e-05	6.61e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	1.54e-05	6.61e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK14—coronary artery disease	1.54e-05	6.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—coronary artery disease	1.54e-05	6.57e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—coronary artery disease	1.53e-05	6.56e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KIT—coronary artery disease	1.53e-05	6.54e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	1.52e-05	6.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	1.52e-05	6.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—coronary artery disease	1.52e-05	6.5e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ESR1—coronary artery disease	1.51e-05	6.46e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.49e-05	6.39e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.49e-05	6.39e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—F2—coronary artery disease	1.49e-05	6.38e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FN1—coronary artery disease	1.49e-05	6.38e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.49e-05	6.38e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6ST—coronary artery disease	1.48e-05	6.36e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—coronary artery disease	1.48e-05	6.34e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	1.48e-05	6.33e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NFKBIA—coronary artery disease	1.47e-05	6.31e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	1.47e-05	6.27e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CTGF—coronary artery disease	1.46e-05	6.25e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—coronary artery disease	1.45e-05	6.22e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	1.45e-05	6.22e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.45e-05	6.19e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT2—coronary artery disease	1.45e-05	6.19e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	1.44e-05	6.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	1.44e-05	6.15e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KIT—coronary artery disease	1.43e-05	6.11e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	1.42e-05	6.09e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	1.42e-05	6.07e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—coronary artery disease	1.42e-05	6.06e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	1.41e-05	6.04e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	1.4e-05	5.99e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	1.39e-05	5.96e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	1.38e-05	5.91e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—C3—coronary artery disease	1.38e-05	5.9e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	1.37e-05	5.86e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—coronary artery disease	1.36e-05	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	1.36e-05	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—coronary artery disease	1.34e-05	5.73e-05	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.33e-05	5.69e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.33e-05	5.69e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	1.33e-05	5.69e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	1.33e-05	5.69e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	1.32e-05	5.67e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—coronary artery disease	1.32e-05	5.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	1.32e-05	5.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—coronary artery disease	1.31e-05	5.61e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	1.31e-05	5.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—coronary artery disease	1.3e-05	5.58e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.3e-05	5.58e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	1.3e-05	5.57e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—coronary artery disease	1.3e-05	5.55e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.29e-05	5.52e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	1.29e-05	5.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—coronary artery disease	1.28e-05	5.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—coronary artery disease	1.28e-05	5.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	1.27e-05	5.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	1.27e-05	5.43e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KDR—coronary artery disease	1.26e-05	5.39e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.25e-05	5.35e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GGT1—coronary artery disease	1.25e-05	5.34e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT1—coronary artery disease	1.25e-05	5.34e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.24e-05	5.32e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	1.24e-05	5.31e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	1.23e-05	5.28e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.23e-05	5.25e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.21e-05	5.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.21e-05	5.18e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	1.21e-05	5.17e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1.21e-05	5.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—coronary artery disease	1.2e-05	5.15e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	1.2e-05	5.14e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	1.2e-05	5.12e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	1.18e-05	5.07e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.16e-05	4.96e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	1.15e-05	4.93e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—coronary artery disease	1.15e-05	4.93e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.13e-05	4.83e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.12e-05	4.81e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.12e-05	4.8e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.11e-05	4.76e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.11e-05	4.76e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.11e-05	4.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.1e-05	4.72e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.1e-05	4.72e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAT—coronary artery disease	1.09e-05	4.67e-05	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.09e-05	4.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.08e-05	4.62e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.08e-05	4.61e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.08e-05	4.61e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.07e-05	4.58e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.06e-05	4.54e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOB—coronary artery disease	1.06e-05	4.53e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.06e-05	4.52e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.05e-05	4.5e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.05e-05	4.5e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.05e-05	4.49e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.03e-05	4.41e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.02e-05	4.35e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.01e-05	4.34e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—coronary artery disease	1.01e-05	4.33e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.01e-05	4.32e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.01e-05	4.31e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.01e-05	4.3e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	9.99e-06	4.28e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—coronary artery disease	9.87e-06	4.22e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	9.87e-06	4.22e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	9.79e-06	4.19e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	9.75e-06	4.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	9.62e-06	4.12e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—coronary artery disease	9.61e-06	4.11e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	9.5e-06	4.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPP2CA—coronary artery disease	9.49e-06	4.06e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	9.35e-06	4e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	9.22e-06	3.95e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	9.16e-06	3.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	9.13e-06	3.91e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—coronary artery disease	9.11e-06	3.9e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—coronary artery disease	8.65e-06	3.7e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	8.53e-06	3.65e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	8.53e-06	3.65e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—coronary artery disease	8.48e-06	3.63e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	8.38e-06	3.59e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—coronary artery disease	8.38e-06	3.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	8.24e-06	3.53e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	8.22e-06	3.52e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	8.17e-06	3.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	8.11e-06	3.47e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.02e-06	3.44e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CA—coronary artery disease	7.97e-06	3.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	7.95e-06	3.4e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	7.83e-06	3.35e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	7.72e-06	3.3e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	7.68e-06	3.29e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	7.49e-06	3.2e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—coronary artery disease	7.38e-06	3.16e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—coronary artery disease	7.28e-06	3.12e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	7.13e-06	3.05e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	6.93e-06	2.97e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	6.66e-06	2.85e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—coronary artery disease	6.64e-06	2.84e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—coronary artery disease	6.51e-06	2.79e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CA—coronary artery disease	6.47e-06	2.77e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	6.36e-06	2.72e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—coronary artery disease	6.35e-06	2.72e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—coronary artery disease	6.32e-06	2.7e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	6.24e-06	2.67e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—coronary artery disease	5.9e-06	2.53e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	5.83e-06	2.5e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—coronary artery disease	5.81e-06	2.49e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	5.44e-06	2.33e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	5.41e-06	2.32e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—coronary artery disease	5.29e-06	2.26e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—coronary artery disease	4.79e-06	2.05e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	4.42e-06	1.89e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.57e-06	1.53e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—coronary artery disease	2.92e-06	1.25e-05	CbGpPWpGaD
